Crossmark

A trial of fetal cells for Parkinson’s disease brings lessons for the field

Crossref DOI link: https://doi.org/10.1038/s41587-025-02742-5

Published Online: 2025-06-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tabar, Viviane https://orcid.org/0000-0002-1284-1670
License Information

Text and Data Mining valid from 2025-06-26

Version of Record valid from 2025-06-26
More Information

Article History

First Online: 26 June 2025

Competing interests

: V. Tabar is a scientific consultant for BlueRock Therapeutics.